New South Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.1M | Buy |
155,834
+21,580
| +16% | +$10.4M | 3.43% | 10 |
|
|
2026
Q1 | $66M | Sell |
134,254
-12,204
| -8% | -$6.62M | 3.16% | 8 |
|
|
2025
Q4 | $84.9M | Sell |
146,458
-1,832
| -1% | -$1.04M | 3.9% | 7 |
|
|
2025
Q3 | $71.9M | Sell |
148,290
-2,413
| -2% | -$1.12M | 3.28% | 9 |
|
|
2025
Q2 | $61.1M | Sell |
150,703
-1,660
| -1% | -$694K | 2.96% | 9 |
|
|
2025
Q1 | $75.8M | Sell |
152,363
-3,691
| -2% | -$2M | 3.66% | 7 |
|
|
2024
Q4 | $81.2M | Buy |
156,054
+209
| +0.1% | +$115K | 3.42% | 6 |
|
|
2024
Q3 | $96.4M | Sell |
155,845
-2,751
| -2% | -$1.63M | 3.94% | 6 |
|
|
2024
Q2 | $87.7M | Sell |
158,596
-530
| -0.3% | -$304K | 3.92% | 6 |
|
|
2024
Q1 | $92.5M | Sell |
159,126
-4,769
| -3% | -$2.68M | 3.87% | 7 |
|
|
2023
Q4 | $87M | Sell |
163,895
-4,933
| -3% | -$2.39M | 3.79% | 6 |
|
|
2023
Q3 | $85.5M | Sell |
168,828
-1,744
| -1% | -$929K | 4.08% | 6 |
|
|
2023
Q2 | $89M | Sell |
170,572
-11,159
| -6% | -$6.02M | 3.96% | 6 |
|
|
2023
Q1 | $105M | Sell |
181,731
-3,200
| -2% | -$1.8M | 4.76% | 6 |
|
|
2022
Q4 | $102M | Sell |
184,931
-4,424
| -2% | -$2.34M | 4.69% | 5 |
|
|
2022
Q3 | $96M | Sell |
189,355
-3,658
| -2% | -$2.05M | 4.65% | 5 |
|
|
2022
Q2 | $105M | Sell |
193,013
-2,867
| -1% | -$1.58M | 4.79% | 3 |
|
|
2022
Q1 | $116M | Sell |
195,880
-7,181
| -4% | -$4.13M | 4.34% | 4 |
|
|
2021
Q4 | $135M | Sell |
203,061
-7,788
| -4% | -$4.86M | 4.49% | 5 |
|
|
2021
Q3 | $120M | Sell |
210,849
-42,977
| -17% | -$23.6M | 4.19% | 7 |
|
|
2021
Q2 | $128M | Sell |
253,826
-5,412
| -2% | -$2.55M | 3.57% | 6 |
|
|
2021
Q1 | $118M | Sell |
259,238
-2,597
| -1% | -$1.24M | 3.47% | 6 |
|
|
2020
Q4 | $122M | Sell |
261,835
-7,925
| -3% | -$3.72M | 4.04% | 6 |
|
|
2020
Q3 | $119M | Sell |
269,760
-79,102
| -23% | -$32.7M | 4.52% | 5 |
|
|
2020
Q2 | $126M | Sell |
348,862
-42,989
| -11% | -$14.4M | 4.49% | 4 |
|
|
2020
Q1 | $111M | Sell |
391,851
-147,730
| -27% | -$46.6M | 4.93% | 4 |
|
|
2019
Q4 | $175M | Sell |
539,581
-8,778
| -2% | -$2.66M | 4.92% | 4 |
|
|
2019
Q3 | $160M | Sell |
548,359
-105,522
| -16% | -$30.2M | 4.79% | 4 |
|
|
2019
Q2 | $192M | Sell |
653,881
-32,770
| -5% | -$9.03M | 5.69% | 3 |
|
|
2019
Q1 | $188M | Sell |
686,651
-26,707
| -4% | -$6.65M | 5.43% | 3 |
|
|
2018
Q4 | $160M | Sell |
713,358
-45,984
| -6% | -$10.8M | 5.12% | 3 |
|
|
2018
Q3 | $185M | Sell |
759,342
-61,913
| -8% | -$14.2M | 4.94% | 3 |
|
|
2018
Q2 | $170M | Sell |
821,255
-26,470
| -3% | -$5.62M | 4.43% | 4 |
|
|
2018
Q1 | $175M | Sell |
847,725
-36,446
| -4% | -$7.65M | 4.38% | 5 |
|
|
2017
Q4 | $168M | Buy |
884,171
+15,775
| +2% | +$3.02M | 3.9% | 7 |
|
|
2017
Q3 | $164M | Buy |
868,396
+11,605
| +1% | +$2.1M | 3.92% | 5 |
|
|
2017
Q2 | $149M | Sell |
856,791
-18,755
| -2% | -$3.15M | 3.54% | 6 |
|
|
2017
Q1 | $134M | Sell |
875,546
-49,684
| -5% | -$7.59M | 3.12% | 9 |
|
|
2016
Q4 | $131M | Sell |
925,230
-22,097
| -2% | -$3.26M | 3.12% | 9 |
|
|
2016
Q3 | $151M | Buy |
947,327
+3,922
| +0.4% | +$604K | 3.61% | 8 |
|
|
2016
Q2 | $139M | Sell |
943,405
-11,280
| -1% | -$1.66M | 3.44% | 7 |
|
|
2016
Q1 | $135M | Buy |
954,685
+24,022
| +3% | +$3.22M | 3.25% | 10 |
|
|
2015
Q4 | $132M | Sell |
930,663
-14,466
| -2% | -$1.93M | 3.4% | 10 |
|
|
2015
Q3 | $116M | Sell |
945,129
-7,632
| -0.8% | -$994K | 2.91% | 13 |
|
|
2015
Q2 | $124M | Sell |
952,761
-25,235
| -3% | -$3.29M | 3.19% | 8 |
|
|
2015
Q1 | $131M | Buy |
977,996
+174,874
| +22% | +$22.5M | 3.3% | 7 |
|
|
2014
Q4 | $101M | Buy |
803,122
+31,102
| +4% | +$3.78M | 3.04% | 9 |
|
|
2014
Q3 | $94M | Sell |
772,020
-3,448
| -0.4% | -$419K | 3.1% | 9 |
|
|
2014
Q2 | $91.5M | Sell |
775,468
-3,136
| -0.4% | -$369K | 2.85% | 10 |
|
|
2014
Q1 | $93.6M | Sell |
778,604
-142,220
| -15% | -$16.9M | 3.02% | 9 |
|
|
2013
Q4 | $103M | Buy |
920,824
+46,399
| +5% | +$4.61M | 3.58% | 7 |
|
|
2013
Q3 | $80.6M | Buy |
874,425
+1,925
| +0.2% | +$174K | 3.14% | 9 |
|
|
2013
Q2 | $73.8M | Buy |
+872,500
| New | +$72.6M | 3.02% | 10 |
|
Other funds holding TMO
New South Capital Management's TMO Position: Q2 2026 in Review
New South Capital Management increased its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, buying an estimated $10.4M and bringing the position to 155,834 shares worth $78.1M. The position accounts for 3.43% of the portfolio, ranked #10.
New South Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $192M in Q2 2019. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- New South Capital Management held 155,834 shares of Thermo Fisher Scientific worth $78.1M as of Q2 2026.
- New South Capital Management bought 21,580 Thermo Fisher Scientific shares in Q2 2026, an estimated $10.4M.
- Thermo Fisher Scientific made up 3.43% of New South Capital Management's portfolio in Q2 2026, its #10 holding.
- New South Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- New South Capital Management's Thermo Fisher Scientific position peaked at $192M in Q2 2019.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on New South Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.